Your brother will not make the calls. So you are the one with nine tabs open at midnight, trying to work out what comes after the third medication that did not help.

The most useful thing our paid survey of 443 Midwest adults turned up is this. Asked which voice could persuade them toward ketamine-type therapy, respondents gave their own doctor 74 percent and an ad 2. A gap of 74 to 2 is not a rounding question.

Treat that as a map. The person you are helping is far likelier to accept a treatment that arrives through a physician they trust than one a relative found online after midnight. So tonight's job is not to pick a clinic. It is to walk into a doctor's office with a short, checkable list and a clear question.

Step 1. Name the goal before you open a browser

The goal is a conversation with a prescribing clinician, backed by two or three options you have already vetted, not a booking or a deposit. Most respondents would take the same route: 56 percent named the primary doctor as step one, 23 percent a psychiatrist or therapist, and 12 percent a solo online search.

Step 2. Build a shortlist of settings, not brand names

  • The behavioral health department of the hospital system they already use
  • Their psychiatry practice, if they have one, or the one the primary doctor refers to
  • Any academic medical center within driving distance, which often runs more specialized programs
  • The insurer's provider directory, filtered for behavioral health
  • If they carry TRICARE, the plan itself, which can explain its own referral rules

Three candidates is plenty. A list of fifteen is a list you will never call.

Step 3. Find out what kind of place each one is

People skip this step, and it matters most, because two very different things share a word. Spravato, which is esketamine, has an FDA approval covering depression that other treatment has failed to lift; the spray is taken on site at a certified clinic, under supervision, and the patient is monitored before heading home. At-home ketamine, usually a compounded product mailed after a video visit, is a different and much grayer category. They are not two flavors of one thing, whatever a homepage implies. Brain Recovery Centers' page on Spravato treatment is one example of how a certified program describes itself.

For each place, get plain answers. Is it certified for esketamine, a different ketamine service, or both? Who prescribes, with what credentials? Who is present during and after a session, and for how long? Does the patient need a driver? Does the person stay in ongoing psychiatric care? What happens, concretely, if something goes wrong? A reputable program answers without hedging.

Step 4. Check the coverage before you dial

Money mattered more than distance in our survey. Asked for their two biggest provider priorities, 85 percent included insurance; nearness was next at 43 percent, then FDA approval (27 percent) and speed (24), discretion 11, and practices that focus on service members 10.

So spend your first call on the insurer, member ID in hand, asking for behavioral health benefits and noting the call reference number. Ask whether esketamine is covered and whether claims go through the medical or pharmacy side, whether prior authorization is required and what a doctor must document, which nearby facilities are in network, and what the patient pays per session, including any separate charge for monitoring time. A price that covers the drug but not the hours of supervision is not a price.

Step 5. Call the front desk and ask plainly

Ask whether they are in network for this specific service, whether they need a referral before scheduling, what records to send ahead, how many weeks out a first evaluation sits, how much time to block for a session, and whether a family member can join intake. If they cannot say whether a referral is needed, or will not put a cost range in writing, weigh that against a place that will.

Step 6. Match the format to the person, not the calendar

Asked how they would want this delivered, 44 percent of respondents chose an in-person clinic; home telehealth got 22 percent and the clinic-first, home-later plan got 23, and 11 percent had no preference. Weigh it honestly. Someone barely leaving the house may not manage a twice-weekly drive, and someone without a reliable ride cannot commit to a monitoring period that requires one. The right format is the one the person can still keep in week six, and the supervision built into approved esketamine is a requirement, not a convenience to negotiate away.

Step 7. Bring it back to the doctor who knows them

Now book with the primary doctor or psychiatrist and bring one page: what has been tried, what happened, the settings you vetted, and what the insurer said. Then ask whether any of it is worth considering for this person. That question belongs to a clinician who knows the full history, other conditions and medications included. No survey can say whether a treatment fits one person; ours can only say whose opinion the patient is most likely to act on, which is why the list belongs in a doctor's hands, not a group text.

Step 8. When the answer is no

Sometimes it is no, and sometimes no is right. Ask for the reasoning, what would need to change, what they would try instead, and whether a psychiatrist should weigh in. Then keep the record of dates, medications, doses, durations, and why each stopped; that page moves more cases forward than any brochure. And pace yourself, because caregiving through depression is long work that goes better with your own support in place.

This last point matters more than everything above. If the person you are helping has begun to say they would rather not be here, skip the waiting list. Reach 988 by call or text, day or night; its counselors also coach family members on helping someone else.

Methodology

The publisher funded and commissioned survey 395586438; Pollfish ran it with members of its consumer panel until June 23, 2026. By the close, 443 people from ten Midwest states, all 18 to 64, had responded. On multi-answer questions each share is a percentage of respondents, so totals top 100. Every figure is from the panel's final validation.